FI62089C - Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat - Google Patents

Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat Download PDF

Info

Publication number
FI62089C
FI62089C FI753543A FI753543A FI62089C FI 62089 C FI62089 C FI 62089C FI 753543 A FI753543 A FI 753543A FI 753543 A FI753543 A FI 753543A FI 62089 C FI62089 C FI 62089C
Authority
FI
Finland
Prior art keywords
ethyl
hydroxy
formula
propyl
benzyloxyphenoxy
Prior art date
Application number
FI753543A
Other languages
English (en)
Finnish (fi)
Other versions
FI62089B (fi
FI753543A (nl
Inventor
Wilhelm Konz
Richard Reichl
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI753543A publication Critical patent/FI753543A/fi
Publication of FI62089B publication Critical patent/FI62089B/fi
Application granted granted Critical
Publication of FI62089C publication Critical patent/FI62089C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI753543A 1974-12-21 1975-12-16 Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat FI62089C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2460929 1974-12-21
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (3)

Publication Number Publication Date
FI753543A FI753543A (nl) 1976-06-22
FI62089B FI62089B (fi) 1982-07-30
FI62089C true FI62089C (fi) 1982-11-10

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
FI753543A FI62089C (fi) 1974-12-21 1975-12-16 Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat

Country Status (31)

Country Link
US (1) US3998953A (nl)
JP (1) JPS5188995A (nl)
AT (1) AT341540B (nl)
AU (1) AU501889B2 (nl)
BE (1) BE836898A (nl)
BG (1) BG25518A3 (nl)
CA (1) CA1036159A (nl)
CH (1) CH628346A5 (nl)
CS (1) CS191289B2 (nl)
DD (1) DD124984A5 (nl)
DE (1) DE2460929A1 (nl)
DK (1) DK137677C (nl)
ES (2) ES443738A1 (nl)
FI (1) FI62089C (nl)
FR (1) FR2294706A1 (nl)
GB (1) GB1517710A (nl)
GR (1) GR59204B (nl)
HU (1) HU174673B (nl)
IE (1) IE43208B1 (nl)
IL (1) IL48697A (nl)
LU (1) LU73972A1 (nl)
NL (1) NL7514837A (nl)
NO (1) NO144928C (nl)
NZ (1) NZ179599A (nl)
PH (1) PH11810A (nl)
PL (1) PL99165B1 (nl)
RO (1) RO68381A (nl)
SE (1) SE420493B (nl)
SU (1) SU603340A3 (nl)
YU (1) YU39004B (nl)
ZA (1) ZA757865B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (nl) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (nl) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
RO68381A (ro) 1982-02-26
FI62089B (fi) 1982-07-30
ES451457A1 (es) 1977-10-01
AT341540B (de) 1978-02-10
US3998953A (en) 1976-12-21
NO144928C (no) 1981-12-09
IE43208L (en) 1976-06-21
NO144928B (no) 1981-08-31
SE420493B (sv) 1981-10-12
NL7514837A (nl) 1976-06-23
AU8754775A (en) 1977-06-23
IL48697A (en) 1979-07-25
ZA757865B (en) 1977-08-31
DK137677B (da) 1978-04-17
GB1517710A (en) 1978-07-12
JPS5188995A (nl) 1976-08-04
ES443738A1 (es) 1977-04-16
CS191289B2 (en) 1979-06-29
SU603340A3 (ru) 1978-04-15
CA1036159A (en) 1978-08-08
FR2294706A1 (fr) 1976-07-16
IE43208B1 (en) 1981-01-14
NZ179599A (en) 1978-03-06
NO754317L (nl) 1976-06-22
YU323475A (en) 1982-08-31
PH11810A (en) 1978-07-10
CH628346A5 (de) 1982-02-26
DE2460929C2 (nl) 1987-12-17
AU501889B2 (en) 1979-07-05
DE2460929A1 (de) 1976-06-24
LU73972A1 (nl) 1977-02-15
BG25518A3 (en) 1978-10-10
ATA904575A (de) 1977-06-15
DD124984A5 (nl) 1977-03-23
GR59204B (en) 1977-11-26
FI753543A (nl) 1976-06-22
DK137677C (da) 1978-09-25
FR2294706B1 (nl) 1978-12-01
SE7514477L (sv) 1976-06-22
HU174673B (hu) 1980-03-28
PL99165B1 (pl) 1978-06-30
YU39004B (en) 1983-12-31
IL48697A0 (en) 1976-02-29
DK571875A (da) 1976-06-22
BE836898A (fr) 1976-06-21

Similar Documents

Publication Publication Date Title
US6294517B1 (en) Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
SU1375127A3 (ru) Способ получени производных 1,2-диаминоциклобутен-3,4-диона или их хлоргидратов
FI62089C (fi) Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat
SK81894A3 (en) Adenosine derivatives, preparation method and pharmaceutical compositions containing them
SK319892A3 (en) N-phenyl-2-cyano-3-hydroxycrotonamide derivatives, method of their poduction and their using for manufacture of medicines with immunomodulating effect
JPS6322082A (ja) １―（ヒドロキシスチリル）―５ｈ―２，３―ベンゾジアゼピン誘導体およびその製造方法、並びに前記誘導体を含む薬剤
US4182757A (en) Novel nitrosourea compounds and process for preparing the same
EP0301936B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
FR2483929A1 (fr) Nouvelles adenosines n6-substituees utiles comme medicaments antihypertenseurs, compositions therapeutiques et formes pharmaceutiques les contenant, et leur procede de preparation
SU1391495A3 (ru) Способ получени производных 3-фенил-2-пропенамина в виде Z-изомеров или их терапевтически совместимых солей
US4857536A (en) Antihistaminic benzimidazole derivatives
NL8301269A (nl) Werkwijze ter bereiding van nieuwe furanderivaten.
JPS58116477A (ja) 抗高血圧剤としてのパ−ヒドロ−１，４−チアゼピン−５−オンおよびパ−ヒドロ−１，４−チアゾシン−５−オン誘導体
SU791241A3 (ru) Способ получени производных 4,5,6,7-тетрагидроимидазо 4,5-с пиридина
FI77028C (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbart 4-(1-imidatzolylmetyl)kanelsyrahydroklorid- monohydrat.
KR850001880B1 (ko) 트란스-4-[n-(3', 4'-메틸렌디옥시벤질리덴)아미노메틸] 사이클로헥산-1-카복실산 및 이의 유도체의 제조방법
SK278141B6 (en) Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n- -(2-pyridyl)-2h-thieno(2,3-e)1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent
FI81802C (fi) Foerfarande foer framstaellning av terapeutiskt verksamt 2-(3-metoxi-5-metyltio- eller 5-metylsulfinyl-2-tienyl-1h-imidazo(4,5-c)pyridin.
FI85481C (fi) Foerfarande foer framstaellning av 2,3 -dihydro-1-(8-metyl-1,2,4-triazolo/4,3-b/pyridazin-6-yl)-4(1h) -pyridinon.
JPH0680041B2 (ja) ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
KR830002843B1 (ko) 알킬-케토헥소 피라노사이드 유도체의 제조방법
US4235912A (en) Biologically active new 8β-hydrazinomethyl-ergoline derivatives and a process for the preparation thereof
EP0119500B1 (en) Novel isoprenylic acid amide derivatives, processes for their preparation and pharmaceutical compositions containing them
SU1373323A3 (ru) Способ получени 2-амино-9-(2-оксиэтоксиметил)-9Н-пурина (его варианты)
RU1797489C (ru) Способ лечени респираторных болезней тел т

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: C.H. BOEHRINGER SOHN